Eltrocib-25 Tablet 7's

Eltrocib-25 Tablet 7's is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Eltrocib-25 Tablet 7's is also used to treat severe aplastic anemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anemia is a condition in which the bone marrow doesn't make enough blood cells.

Eltrocib-25 Tablet 7's contains Eltrombopag, which belongs to the class of 'thrombopoietin receptor agonists. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Eltrocib-25 Tablet 7's works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Eltrocib-25 Tablet 7's helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.

In some cases, Eltrocib-25 Tablet 7's can cause common side effects like nausea, diarrhea, headache, muscle pain, tiredness, loss of appetite, fever, anemia (lack of blood cells), cough, and tingling numbness. If you notice any side effects that are not manageable, please consult your doctor.

Let your doctor know if you have any allergic reactions to Eltrocib-25 Tablet 7's or any other medicines before starting Eltrocib-25 Tablet 7's. Consult the doctor if you are pregnant or planning to conceive. Eltrocib-25 Tablet 7's is not indicated for use in breastfeeding since it passes into the breast milk.

Eltrocib-25 Tablet 7's is used to treat low platelet count and severe aplastic anemia (SAA). The detailed uses of Eltrocib-25 Tablet 7's are as follows:

• Chronic immune thrombocytopenia (ITP): Eltrocib-25 Tablet 7's helps prevent excessive bleeding in patients with low platelet counts.
• Severe aplastic anemia: Eltrocib-25 Tablet 7's is used to treat severe aplastic anemia when other treatments have failed.
• Chronic hepatitis C-related thrombocytopenia: Eltrocib-25 Tablet 7's helps maintain platelet levels before and during interferon therapy.

• Eltrocib-25 Tablet 7's can be taken with or without food.
• Follow your doctor's instructions on the dosage and timing of this medication.
• Shake well before use. Measure the prescribed dose using a measuring cup and administer it orally.
• Avoid using regular household spoons, as they may not measure the dose correctly.

• Eltrocib-25 Tablet 7's contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia (SAA).
• Eltrocib-25 Tablet 7's works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets.
• The increase in these bone marrow cells stimulates the production of platelets.
• Thus, Eltrocib-25 Tablet 7's prevents bleeding episodes by increasing the number of platelets in the blood.

• If you are known to be allergic to Eltrocib-25 Tablet 7's or other medicines, please inform your doctor in advance.
• Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Eltrocib-25 Tablet 7's.
• Take Eltrocib-25 Tablet 7's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltrocib-25 Tablet 7's.
• It is not recommended during pregnancy since it may have harmful effects on the foetus.
• Consult your doctor before using Eltrocib-25 Tablet 7's if you are a breastfeeding mother.
• Do not drive or operate machinery since Eltrocib-25 Tablet 7's may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive.
• Avoid or limit alcohol consumption with Eltrocib-25 Tablet 7's as it may affect the efficacy of Eltrocib-25 Tablet 7's.
• It is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.